Ra Capital Management, L.P. - Jul 1, 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
ETNB
Transactions as of
Jul 1, 2022
Transactions value $
$10,002,812
Form type
4
Date filed
7/6/2022, 05:27 PM
Previous filing
Jun 23, 2022
Next filing
Jul 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Purchase $10M +2.82M +56.73% $3.55 7.78M Jul 1, 2022 See Footnotes F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Warrants (Right to Buy) Purchase $2.82K +2.82M $0.00* 1.41M Jul 1, 2022 Common Stock 1.41M $5.33 See footnotes F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund L.P. (the "Nexus Fund").
F2 These Securities are held solely by the Fund.
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Mr. Derek DiRocco, a Partner of the Adviser, serves on the Issuer's board of directors.